COMING SOON
Set the Standard
Distinction in Ig Therapy
Setting the Standard in Ig Therapy
Developed in collaboration with IgNS, the Distinction in Ig Therapy validates provider excellence in the delivery of immunoglobulin therapy. The distinction standards align the expertise of IgNS in clinician preparation and competencies with ACHC’s focus on quality and safety at the organizational level.
The result? A new step forward in improving quality, credibility, and patient outcomes in immunoglobulin therapy.

Discover More
Be the first to know when the Distinction in Ig Therapy launches.